SCHEMBL7704500

SCHEMBL7704500

CC[Si](CC)(CC)OS(=O)(=O)O

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.40
TSHR P16473 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28457187 0.82 CA2 (0.31) CA2
SCHEMBL608487 0.79 CA1 (0.30) CA2
SCHEMBL7706979 0.79 CA2 (0.36) CA2
SCHEMBL7707430 0.75 CA2 (0.34) CA2
SCHEMBL2057519 0.74
SCHEMBL10726217 0.74
SCHEMBL7707593 0.74 CA2 (0.37) CA2
SCHEMBL17466331 0.72 USP2 (0.33) CA2TSHR
SCHEMBL7041191 0.72
SCHEMBL5960758 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6350546-B1 Sulfate additives for nonaqueous electrolyte rechargeable cells WILSON GREATBATCH LTD. 2002-02-26 US claimed
US-6265106-B1 HIGH CURRENT PULSES AND CAPACITY; ORGANIC SULFATE ADDITIVE WILSON GREATBATCH LTD. 2001-07-24 US claimed
EP-1109244-A2 Sulfate additives for nonaqueous electrolyte rechargeable cells WILSON GREATBATCH LTD. (US) 2001-06-20 EP claimed
US-6180283-B1 Method for reducing voltage delay in an alkali metal electrochemical cell activated with a nonaqueous electrolyte having a sulfate additive WILSON GREATBATCH LTD. 2001-01-30 US claimed
US-12091491-B2 Silylamine compound and latent curing agent comprising said silylamine compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2024-09-17 US disclosed
CN-111095656-B Lithium secondary battery 三星SDI株式会社 2024-03-22 CN disclosed
CN-112930352-B Silylamine compounds and latent curing agents containing the same 广荣化学株式会社 2024-02-13 CN disclosed
CN-111527085-B 5- (2, 5-bis (4-chloro-2-isopropylphenyl) thiophen-3-yl) -1H-tetrazole for topical treatment of bacterial infections 德诺瓦姆德有限公司 2023-09-12 CN disclosed
CN-112166109-B Diphenyl-substituted thiophene-2-amide derivatives as antimicrobial agents and pharmaceutical compositions thereof 德诺瓦姆德有限公司 2023-09-12 CN disclosed
US-11721837-B2 Lithium secondary battery including fluoroethylene carbonate in electrolyte SAMSUNG SDI CO., LTD. (KR) 2023-08-08 US disclosed
US-11626619-B2 Non-aqueous electrolyte for lithium secondary battery and lithium secondary battery comprising same SAMSUNG SDI CO., LTD. (KR) 2023-04-11 US disclosed
US-20220119583-A1 SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-04-21 US disclosed
EP-3875461-A1 SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND Koei Chemical Company, Limited (JP) 2021-09-08 EP disclosed
CN-112930352-A Silylamine compound and latent curing agent containing the same 广荣化学株式会社 2021-06-08 CN disclosed
CN-112166109-A Diphenyl substituted thiophene-2-amide derivatives and pharmaceutical compositions thereof as antimicrobial agents 德诺瓦姆德有限公司 2021-01-01 CN disclosed
CN-111527085-A 5- (2, 5-bis (4-chloro-2-isopropylphenyl) thiophen-3-yl) -1H-tetrazoles for topical treatment of bacterial infections 德诺瓦姆德有限公司 2020-08-11 CN disclosed
US-6350546-B1 Sulfate additives for nonaqueous electrolyte rechargeable cells WILSON GREATBATCH LTD. 2002-02-26 US disclosed
US-6265106-B1 HIGH CURRENT PULSES AND CAPACITY; ORGANIC SULFATE ADDITIVE WILSON GREATBATCH LTD. 2001-07-24 US disclosed
EP-1109244-A2 Sulfate additives for nonaqueous electrolyte rechargeable cells WILSON GREATBATCH LTD. (US) 2001-06-20 EP disclosed
US-6180283-B1 Method for reducing voltage delay in an alkali metal electrochemical cell activated with a nonaqueous electrolyte having a sulfate additive WILSON GREATBATCH LTD. 2001-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11626619-B2 Non-aqueous electrolyte for lithium secondary battery and lithium secondary battery comprising same SLC26A3, CLCN2, SLC9B2 CA2 119/4885TSHR 4096/4885TDP1 2066/4885
US-11721837-B2 Lithium secondary battery including fluoroethylene carbonate in electrolyte SLC9B2, RER1, SLC9A5 CA2 190/4885TSHR 3721/4885TDP1 2025/4885
US-20220119583-A1 SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND CDKN1A, SIRT2, H1-4 CA2 994/4885TSHR 4800/4885TDP1 4572/4885
US-12091491-B2 Silylamine compound and latent curing agent comprising said silylamine compound CDKN1A, SIRT2, H1-4 CA2 994/4885TSHR 4800/4885TDP1 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.